Nearing the Finish Line: Steady Progress in the Development of Complement Inhibitors for Glomerular Disease.
Thurman JM. Nearing the Finish Line: Steady Progress in the Development of Complement Inhibitors for Glomerular Disease. Kidney Int Rep. 2025 Feb; 10(2):302-305.